SHIELD THERAPEUTICS
Shield Therapeutics is an independent specialty pharmaceutical company focused on the development and commercialisation of late-stage, mineral-derived hospital pharmaceuticals which address areas of high unmet medical need. During 2011 Shield will be commencing global pivotal Phase III studies of its lead asset, ST10-021, for the treatment of iron deficiency anaemia associated with inflammatory bowel disease and subsequently chronic kidney disease. The Company is headquartered in Wollerau, Switzerland.
SHIELD THERAPEUTICS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2008-01-01
Address:
Weybridge, Surrey, United Kingdom
Country:
United Kingdom
Website Url:
http://www.shieldtherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
8.2 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Font Awesome Nginx YouTube Person Schema Gravatar Profiles Typekit Amazon SSL
Current Employees Featured
Founder
Stock Details
Investors List
Inventages Venture Capital Investment Inc.
Inventages Venture Capital Investment Inc. investment in Series A - Shield Therapeutics
Official Site Inspections
http://www.shieldtherapeutics.com
- Host name: 167.99.200.154
- IP address: 167.99.200.154
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
More informations about "Shield Therapeutics"
About Us - Shield Therapeutics plc
Shield Therapeutics is a patient-focused, commercial stage pharmaceutical company on a mission to improve the lives of people suffering from iron deficiency, enabling them to enjoy the things that make a difference in their …See details»
Shield Therapeutics plc - LinkedIn
Shield Therapeutics plc confirms its audited results for the year ended 31 December 2024. 2024 reflected a significant step-up in revenue, alongside making substantial progress in expanding …See details»
Shield Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
View Shield Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Shield Therapeutics - Overview, News & Similar companies
Popular Searches Shield Therapeutics PLC Shield Therapeutics Shieldtherapeutics Shield Tx Shield Tx( UK) Ltd SIC Code 87,873 NAICS Code 54,541 Ticker LON: STX.L Show more. …See details»
Shield Therapeutics (SHIEF) Company Profile & Description - Stock …
Jan 31, 2025 Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat …See details»
Shield Therapeutics - Craft
Shield Therapeutics has 5 employees across 5 locations, $11.81 m in total funding, and £11.88 m in annual revenue in FY 2018. See insights on Shield Therapeutics including office locations, …See details»
Shield Therapeutics plc Company Overview, Contact Details
[email protected]: 6%. [email protected]: [email protected]: 5%. See more formats. Frequently Asked Questions Where is …See details»
Our Difference - Shield Therapeutics plc
Our people in the organization are a source of pride. We have put together an outstanding team of individuals that are focused on achieving our goals and our mission ‘to improve lives …See details»
Shield Therapeutics (Switzerland) AG – Swiss Biotech
Shield is a commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia. Our clear purpose is to develop products that help patients …See details»
Shield Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Shield Therapeutics is an independent specialty pharmaceutical company focused on the development and commercialisation of late-stage, …See details»
Shield Therapeutics Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Shield Therapeutics Inc of Wellesley, MA. Get the latest business insights from Dun & Bradstreet.See details»
Home | Shield Therapeutics plc
The unmet need of iron deficiency We deliver innovative specialty pharmaceuticals that address a significant unmet need for patients suffering from iron deficiency, with or without anemia.See details»
Shield Therapeutics Company Profile | Management and
Www.shieldtherapeutics.com Shield Therapeutics Profile and History Shield is a de-risked, commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals to …See details»
Shield Therapeutics plc - Walbrook
Oct 31, 2024 Shield is a commercial stage pharmaceutical company focused on the commercialisation of Accrufer®/Feraccru® (ferric maltol), an innovative oral iron therapy for …See details»
KYE Pharma
For more information, please visit www.shieldtherapeutics.com. About KYE Pharmaceuticals Inc. KYE Pharmaceuticals is a private company headquartered in Canada focused on bringing …See details»
News | Shield Therapeutics plc
Dec 31, 2024 See latest news from Shield Therapeutics plc. Shield Therapeutics plc (LSE: STX), has concluded the formal loan documentation (the “Shareholder Loan Agreement”) in …See details»
Shield Therapeutics PLC, SHIEF:QBB profile - FT.com - Financial …
5 days ago Shield Therapeutics plc is a United Kingdom-based commercial-stage pharmaceutical company. The Company delivers differentiated specialty pharmaceuticals that …See details»
Investors - Shield Therapeutics plc
Our focus is our people, patients, partnerships and products to create a working culture founded on our core values. It’s through this collaboration and alignment we’re able to attract highly …See details»
Global Partners - Shield Therapeutics plc
Collaborating and partnering is key to achieving our global success At Shield, we are focused on ensuring our medicines are accessible to as many people living with iron deficiency anemia as …See details»
Medicines - Shield Therapeutics plc
Shield Therapeutics is a patient-focused, commercial stage pharmaceutical company on a mission to improve the lives of people suffering from iron deficiency, enabling them to enjoy …See details»